Innovating Works

AICURIS ANTI-INFECTIVE CURES

Desconocido
NAKED-C: New late-stage functionalization reagents for the construction of chiral centers to impact drug disc... AICURIS ANTIINFECTIVE CURES AG participó en un HORIZON EUROPE: HORIZON-MSCA-2022-PF-01 Late-stage functionalization (LSF) is a rapidly expanding field in molecular synthesis with the major goal of quickly accessing to derivativ...
2023-07-07 - 2026-07-31 | Financiado
BREAKthrough: Breaking the barrier - An integrated multidisciplinary approach to kill Gram-negative bacteria throu... AICURIS ANTIINFECTIVE CURES AG participó en un HORIZON EUROPE: HORIZON-MSCA-2021-DN-01 Antimicrobial resistance, which is caused by multi-drug-resistant bacterial pathogens is a global health emergency. Gram-negative bacteria (...
2022-07-14 - 2026-12-31 | Financiado
CARE: Corona Accelerated R D in Europe AICURIS ANTIINFECTIVE CURES AG participó en un H2020: H2020-JTI-IMI2-2020-21-single-stage The Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) pandemic has emerged as the largest global health threat to humanity in thi...
2020-08-07 - 2025-03-31 | Financiado
VIRO-FLOW: Enabling Technologies and Drug Discovery Continuous Flow Processes to Discover Novel Antiviral Inhi... AICURIS ANTIINFECTIVE CURES AG participó en un H2020: H2020-MSCA-ITN-2017 VIRO-FLOW project aims to integrate the advantages of continuous flow chemistry with in vitro microfluidic bioassay technologies for the fas...
2017-09-21 - 2021-10-31 | Financiado
Train2Target: An integrated mulTidisciplinary appRoach towards a new generAtIon of aNtibiotics Targeting function... AICURIS ANTIINFECTIVE CURES AG participó en un H2020: H2020-MSCA-ITN-2016 Train2Target is a multidisciplinary European Training Network built to address the challenge of the discovery of alternative antimicrobials....
2016-08-31 - 2020-12-31 | Financiado
COMBACTE-MAGNET: Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections AICURIS ANTIINFECTIVE CURES AG participó en un FP6: Antimicrobial resistance (AMR) is a major global public health threat, and most troublesome is the rapid emergence and dissemination of mult...
2015-01-01 - 2021-12-31 | Financiado
COMBACTE-MAGNET: Combatting Bacterial Resistance in Europe Molecules against Gram Negative Infections AICURIS ANTIINFECTIVE CURES AG participó en un FP7: Antimicrobial resistance (AMR) is a major global public health threat, and most troublesome is the rapid emergence and dissemination of mult...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.